Mayfair Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Sell |
9,862
-795
| -7% | -$19.5K | 0.11% | 155 |
|
|
2025
Q1 | $270K | Sell |
10,657
-101
| -0.9% | -$2.56K | 0.16% | 121 |
|
|
2024
Q4 | $285K | Buy |
10,758
+479
| +5% | +$12.7K | 0.17% | 113 |
|
|
2024
Q3 | $294K | Buy |
10,279
+2,414
| +31% | +$69K | 0.19% | 107 |
|
|
2024
Q2 | $227K | Sell |
7,865
-93
| -1% | -$2.69K | 0.15% | 126 |
|
|
2024
Q1 | $221K | Sell |
7,958
-63
| -0.8% | -$1.75K | 0.16% | 127 |
|
|
2023
Q4 | $238K | Sell |
8,021
-2,236
| -22% | -$66.5K | 0.2% | 108 |
|
|
2023
Q3 | $340K | Sell |
10,257
-3,054
| -23% | -$101K | 0.33% | 66 |
|
|
2023
Q2 | $473K | Sell |
13,311
-283
| -2% | -$10.1K | 0.47% | 47 |
|
|
2023
Q1 | $560K | Sell |
13,594
-286
| -2% | -$11.8K | 0.61% | 40 |
|
|
2022
Q4 | $672K | Buy |
13,880
+218
| +2% | +$10.5K | 0.86% | 30 |
|
|
2022
Q3 | $603K | Sell |
13,662
-529
| -4% | -$23.3K | 0.85% | 31 |
|
|
2022
Q2 | $717K | Buy |
14,191
+17
| +0.1% | +$859 | 0.94% | 26 |
|
|
2022
Q1 | $731K | Sell |
14,174
-77
| -0.5% | -$3.97K | 0.94% | 26 |
|
|
2021
Q4 | $793K | Buy |
14,251
+16
| +0.1% | +$890 | 1.05% | 23 |
|
|
2021
Q3 | $604K | Buy |
14,235
+290
| +2% | +$12.3K | 0.93% | 27 |
|
|
2021
Q2 | $546K | Buy |
13,945
+1,120
| +9% | +$43.9K | 0.87% | 29 |
|
|
2021
Q1 | $466K | Buy |
12,825
+300
| +2% | +$10.9K | 0.83% | 32 |
|
|
2020
Q4 | $461K | Buy |
12,525
+779
| +7% | +$28.7K | 0.9% | 31 |
|
|
2020
Q3 | $409K | Buy |
+11,746
| New | +$409K | 1.05% | 23 |
|